From Basic to Clinical Research in Gastroenteropancreatic Neuroendocrine Tumor Disease – The Clinician-Scientist Perspective

Publisher： Karger

E-ISSN： 1423-0194|80|1|94-98

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.80, Iss.1, 2004-10, pp. : 94-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nuclear Survivin Is a Powerful Novel Prognostic Marker in Gastroenteropancreatic Neuroendocrine Tumor Disease

By  

Neuroendocrinology, Vol. 81, Iss. 1, 2005-05 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease

By  

Neuroendocrinology, Vol. 105, Iss. 1, 2016-08 ,pp. : 90-104

Karger

Access to resources Recommend Favorite

Quality of Clinical Trials in Gastroenteropancreatic Neuroendocrine Tumours

By  

Neuroendocrinology, Vol. 96, Iss. 3, 2012-08 ,pp. : 238-248

Karger

Access to resources Recommend Favorite

Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor

By  

Neuroendocrinology, Vol. 103, Iss. 5, 2015-08 ,pp. : 452-459

Karger

Access to resources Recommend Favorite

When to Look for Von Hippel-Lindau Disease in Gastroenteropancreatic Neuroendocrine Tumors?

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 39-46

Karger

Access to resources Recommend Favorite